AVIGEN(avgn) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AVIGEN(avgn)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Mike McFarland who wrote (143)	9/4/1999 7:20:00 PM
From: scaram(o)uche	Read Replies (2) of 228

Subscribe? To PNAS? DAK recently asked that one of us scientists award you with an honorary degree, which I think we were all willing to do --- throwing in a heaping helping of thanks along with it. But, subscribe to PNAS? That's going too far. You get two honorary degrees...... The "SI honorary scientist" degree, and the "SI drove him to it" degree. - g - --nobody ever followed up to Walkingshadow's post I haven't been commenting because it's not really my field. I don't feel particularly qualified to do much beyond listen and absorb. I agree with you about "sustained" and "non-immunogenic" with respect to the AAV/ARIA results contrasting Adeno and AAV in normal mice. However, there's a difference between having good results and having clear patent rights to practice them. At this point, it looks, to me, like there's enthusiasm concerning the AVGN patents. Does that make sense? Am I forgiven for having mentioned positive stuff in a thread other than the ARIA thread? I'm not drawing conclusions based on expertise in the area, but from having watched the patents issue and then having watched the price charts. AVGN's went up. Don't get mad at me, as this is 20-20 hindsight. - g - patent.womplex.ibm.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next